Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 418 (Search time: 0.009 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016The genomic landscape of core-binding factor acute myeloid leukemiasFaber, Z.; Chen, X.; Gedman, A.; Boggs, K.; Cheng, J.; Ma, J.; Radtke, I.; Chao, J.; Walsh, M.; Song, G.; Andersson, A.; Dang, J.; Dong, L.; Liu, Y.; Huether, R.; Cai, Z.; Mulder, H.; Wu, G.; Edmonson, M.; Rusch, M.; et al.
2015Association of cardiometabolic multimorbidity with mortalityEmerging Risk Factors Collaboration; Di Angelantonio, E.; Kaptoge, S.; Wormser, D.; Willeit, P.; Butterworth, A.; Bansal, N.; O'Keeffe, L.; Gao, P.; Wood, A.; Burgess, S.; Freitag, D.; Pennells, L.; Peters, S.; Hart, C.; Haheim, L.; Gillum, R.; Nordestgaard, B.; Psaty, B.; Yeap, B.; et al.
2015Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 geneBurdon, K.; Fogarty, R.; Shen, W.; Abhary, S.; Kaidonis, G.; Appukuttan, B.; Hewitt, A.; Sharma, S.; Daniell, M.; Essex, R.; Chang, J.; Klebe, S.; Lake, S.; Pal, B.; Jenkins, A.; Govindarjan, G.; Sundaresan, P.; Lamoureux, E.; Ramasamy, K.; Pefkianaki, M.; et al.
2015A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinomaPal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
2012Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysisWormser, D.; Di Angelantonio, E.; Kaptoge, S.; Wood, A.; Gao, P.; Sun, Q.; Walldius, G.; Selmer, R.; Monique Verschuren, W.; Bueno-de-Mesquita, H.; Engström, G.; Ridker, P.; Njølstad, I.; Iso, H.; Holme, I.; Giampaoli, S.; Tunstall-Pedoe, H.; Gaziano, J.; Brunner, E.; Kee, F.; et al.
2014Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant dataHolmes, M.; Dale, C.; Zuccolo, L.; Silverwood, R.; Guo, Y.; Ye, Z.; Prieto-Merino, D.; Dehghan, A.; Trompet, S.; Wong, A.; Cavadino, A.; Drogan, D.; Padmanabhan, S.; Li, S.; Yesupriya, A.; Leusink, M.; Sundstrom, J.; Hubacek, J.; Pikhart, H.; Swerdlow, D.; et al.
2014Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the Center for International Blood and Marrow Transplant ResearchGupta, V.; Malone, A.; Hari, P.; Ahn, K.; Hu, Z.; Gale, R.; Ballen, K.; Hamadani, M.; Olavarria, E.; Gerds, A.; Waller, E.; Costa, L.; Antin, J.; Kamble, R.; van Besien, K.; Savani, B.; Schouten, H.; Szer, J.; Cahn, J.; de Lima, M.; et al.
2014Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?Sabloff, M.; Sobecks, R.; Ahn, K.; Zhu, X.; de Lima, M.; Brown, J.; Inamoto, Y.; Holland, H.; Aljurf, M.; Laughlin, M.; Kamble, R.; Hsu, J.; Wirk, B.; Seftel, M.; Lewis, I.; Arora, M.; Alyea, E.; Kalaycio, M.; Cortes, J.; Maziarz, R.; et al.
2013Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsWaibel, M.; Solomon, V.; Knight, D.; Ralli, R.; Kim, S.; Banks, K.; Vidacs, E.; Virely, C.; Sia, K.; Bracken, L.; Collins-Underwood, R.; Drenberg, C.; Ramsey, L.; Meyer, S.; Takiguchi, M.; Dickins, R.; Levine, R.; Ghysdael, J.; Dawson, M.; Lock, R.; et al.
2017Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemiaBradstock, K.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.; Enno, A.; Schwarer, A.; Lewis, I.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.; Hahn, U.; Cannell, P.; Tiley, C.; Lowenthal, R.; Moore, J.; Cartwright, K.; et al.